Manila (Philippines), April 8
Philippine well being officers have determined to temporarily suspend the use of the AstraZeneca COVID-19 vaccine for people below 60 following studies of uncommon blood clots.
The European Medicines Agency on Wednesday reported a attainable hyperlink however didn’t advocate any age restrictions on utilizing the drug in adults.
The Department of Health and the Food and Drug Administration mentioned consultants have been reviewing info associated to AstraZeneca’s negative effects to give you a suggestion on the vaccine’s use.
AstraZeneca and the vaccine developed by China-based Sinovac Biotech have been the one COVID-19 vaccines obtained to date by the Philippines.
“We continue to underscore that the benefits of vaccination continue to outweigh the risks and we urge everyone to get vaccinated when it’s their turn,” FDA Director General Eric Domingo mentioned.
More than 460,000 doses of AstraZeneca have been administered within the nation to date and tens of millions of doses extra have been ordered by the federal government and personal corporations, Philippine officers mentioned.
The nation’s vaccination marketing campaign has confronted provide issues, supply delays and public hesitancy amid an alarming surge in coronavirus infections. AP